Pfizer’s Zavicefta matches standard-of-care in treating hospital-acquired pneumonia in phase 3…
Results from the phase 3 REPROVE study assessing Pfizer's fixed-dose antibacterial combo Zavicefta (ceftazidime-avibactam) in patients with hospital-acquired pneumonia (HAP)…
Read More...
Read More...
